“Now We See”

Abbelight is advancing how researchers visualize and quantify biology at the smallest scales. Its microscopy and nanoscopy solutions integrate cutting-edge optics, chemistry, and bioinformatic workflows to reveal complex cellular structures with unprecedented clarity and quantitative power. Serving academic institutes and biotech labs, Abbelight’s platform empowers scientists to capture more data, unlock new perspectives on biological mechanisms, and accelerate insights across research domains.

Explore Abbelight

Seeing biology in a new dimension

Understanding biological systems often stalls at the limits of traditional imaging, conventional microscopy can only go so far in resolving sub-cellular structures and dynamics. Researchers need tools that can not only visualize the nanoscale but also deliver reproducible, high-quality data that informs downstream discovery. Without these deeper insights, many mechanistic questions remain unanswered.

A complete imaging workflow built for discovery

Abbelight reimagines bioimaging with a unified end-to-end solution, spanning sample preparation, super-resolution imaging, and advanced data analysis. Its SAFe platform combines automated optics and workflow tools with powerful bioinformatic software, enabling researchers to prepare samples, capture high-throughput images, and extract quantitative insights from complex data sets. With ready-to-use reagents and scalable systems, Abbelight helps labs generate reproducible data while enhancing imaging precision and throughput — accelerating timelines from experiment setup to discovery.

AVANT BIO led Abbelight’s Series B financing to support the company’s next phase of growth, scale adoption of its super-resolution imaging solutions, and expand into key verticals like single-cell phenotyping and mechanism-of-action validation for drug discovery. With a decade of experience in life science research imaging and more than 100 installed systems worldwide, Abbelight is poised to broaden its impact across public research, biotech, biopharma, and CROs. AVANT BIO’s capital, network, and strategic support will accelerate Abbelight’s commercial expansion and help enable wider access to transformative imaging tools that accelerate biological insight and innovation.

Seeing biology in a new dimension

Understanding biological systems often stalls at the limits of traditional imaging, conventional microscopy can only go so far in resolving sub-cellular structures and dynamics. Researchers need tools that can not only visualize the nanoscale but also deliver reproducible, high-quality data that informs downstream discovery. Without these deeper insights, many mechanistic questions remain unanswered.

A complete imaging workflow built for discovery

Abbelight reimagines bioimaging with a unified end-to-end solution, spanning sample preparation, super-resolution imaging, and advanced data analysis. Its SAFe platform combines automated optics and workflow tools with powerful bioinformatic software, enabling researchers to prepare samples, capture high-throughput images, and extract quantitative insights from complex data sets. With ready-to-use reagents and scalable systems, Abbelight helps labs generate reproducible data while enhancing imaging precision and throughput — accelerating timelines from experiment setup to discovery.

AVANT BIO led Abbelight’s Series B financing to support the company’s next phase of growth, scale adoption of its super-resolution imaging solutions, and expand into key verticals like single-cell phenotyping and mechanism-of-action validation for drug discovery. With a decade of experience in life science research imaging and more than 100 installed systems worldwide, Abbelight is poised to broaden its impact across public research, biotech, biopharma, and CROs. AVANT BIO’s capital, network, and strategic support will accelerate Abbelight’s commercial expansion and help enable wider access to transformative imaging tools that accelerate biological insight and innovation.

Vanguards Welcome

We’re eager to connect with life science vanguards.

Tell Us About Your Company

Subscribe

Stay in touch with our latest news and developments

Thanks for subscribing! Check your email for a confirmation message.
Oops! Something went wrong while submitting the form.

Penn 1
250 West 34th Street
New York, New York, 10119